A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer

Abstract About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological and clinical factors are used to select patients f...

Full description

Saved in:
Bibliographic Details
Main Authors: Havjin Jacob, Luka Stanisavljevic, Kristian Eeg Storli, Kjersti E. Hestetun, Olav Dahl, Mette P. Myklebust
Format: article
Language:EN
Published: Nature Portfolio 2018
Subjects:
R
Q
Online Access:https://doaj.org/article/9dd3caffa57b43dc8719f849893eb89b
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items